MACF1 | | | | 0 | 0 |
MAD1L1 | | | | 0 | 0 |
MAF | | | | 0 | 0 |
MAFB | | | | 0 | 0 |
MAGEH1 | 胆管腺癌 | | 吉西他滨, | 1 | 1 |
MAGI2 | | | | 0 | 0 |
MAGOH | | | | 0 | 0 |
MAGOHB | | | | 0 | 0 |
MALT1 | | | | 0 | 0 |
MAML1 | | | | 0 | 0 |
MAML2 | | | | 0 | 0 |
MAML3 | | | | 0 | 0 |
MAN1B1 | | | | 0 | 0 |
MAP2K1 | 结直肠癌,朗格汉斯细胞组织细胞增多症,肺腺癌,黑色素瘤,卵巢浆膜癌 | 西妥昔单抗,达拉非尼,司美替尼,曲美替尼,维莫非尼, | 伊立替康, | 11 | 15 |
MAP2K2 | 黑色素瘤 | 维莫非尼, | | 1 | 1 |
MAP2K3 | | | | 0 | 0 |
MAP2K4 | | | | 0 | 0 |
MAP2K7 | 肺癌 | | | 1 | 1 |
MAP3K1 | | | | 0 | 0 |
MAP3K13 | | | | 0 | 0 |
MAP3K14 | | | | 0 | 0 |
MAP3K4 | | | | 0 | 0 |
MAP4K1 | | | | 0 | 0 |
MAP4K3 | | | | 0 | 0 |
MAP4K5 | | | | 0 | 0 |
MAPK1 | 头颈鳞状细胞癌,非小细胞肺癌 | 厄洛替尼,WZ4002, | | 3 | 4 |
MAPK13 | | | | 0 | 0 |
MAPK14 | | | | 0 | 0 |
MAPK3 | | | | 0 | 0 |
MAPK8 | | | | 0 | 0 |
MAPK8IP1 | | | | 0 | 0 |
MAPK9 | | | | 0 | 0 |
MAPKAP1 | | | | 0 | 0 |
MAPKBP1 | | | | 0 | 0 |
MARK2 | | | | 0 | 0 |
MAX | | | | 0 | 0 |
MB21D2 | | | | 0 | 0 |
MBD4 | | | | 0 | 0 |
MC1R | | | | 0 | 0 |
MCC | | | | 0 | 0 |
MCL1 | | | | 0 | 0 |
MCM3 | | | | 0 | 0 |
MDC1 | | | | 0 | 0 |
MDH2 | | | | 0 | 0 |
MDM2 | 癌症,食道鳞状细胞癌,头颈癌,脂肪肉瘤,恶性胸膜间皮瘤 | MK-8242,派姆单抗(帕博利珠单抗),纳武单抗(纳武利尤单抗),伊匹单抗, | 顺铂,培美曲塞, | 4 | 6 |
MDM4 | 癌症 | 派姆单抗(帕博利珠单抗),纳武单抗(纳武利尤单抗),阿特朱单抗,阿替利珠单抗, | | 2 | 2 |
MECOM | | | | 0 | 0 |
MED12 | | | | 0 | 0 |
MED19 | | | | 0 | 0 |
MEF2B | | | | 0 | 0 |
MEF2C | | | | 0 | 0 |
MEIS1 | | | | 0 | 0 |
MEN1 | 甲状腺损伤细胞癌 | | | 1 | 1 |
MERTK | 黑色素瘤 | UNC1062, | | 1 | 1 |
MET | 癌症,结直肠癌,胃腺癌,多形胶质母细胞瘤,肺腺癌,非小细胞肺癌,肺鳞状细胞癌,乳头状肾细胞癌,皮肤黑色素瘤,胃癌,葡萄膜黑色素瘤 | Anti-EGFR Monoclonal Antibody,卡博替尼,卡马替尼,西妥昔单抗,克唑替尼,厄洛替尼,Foretinib,吉非替尼,MEK Inhibitor,MET Inhibition,ErbB3 Inhibition,Naquotinib,Onartuzumab,奥希替尼,Rilotumumab,沃利替尼,司美替尼,Tepotinib,曲美替尼,维莫非尼, | | 13 | 40 |
MGA | | | | 0 | 0 |
MGMT | 变性少突胶质瘤,多形胶质母细胞瘤,恶性胶质瘤,神经内分泌瘤,少突胶质瘤 | O(6)-benzylguanine,替莫唑胺, | 卡莫司汀,洛莫司汀, | 3 | 13 |
MIA2 | | | | 0 | 0 |
MIB1 | | | | 0 | 0 |
MIDN | | | | 0 | 0 |
MIEN1 | | | | 0 | 0 |
MIOS | | | | 0 | 0 |
MIPOL1 | | | | 0 | 0 |
MIR218-1 | 结直肠癌,胰腺癌 | | | 2 | 3 |
MITF | 黑色素瘤 | PLX4720,司美替尼, | | 1 | 1 |
MKI67 | 乳腺癌,前列腺癌 | | | 1 | 2 |
MKNK1 | | | | 0 | 0 |
MKNK2 | | | | 0 | 0 |
MKRN3 | | | | 0 | 0 |
MLH1 | 林奇综合征,胃癌 | | 奥沙利铂, | 28 | 28 |
MLH3 | | | | 0 | 0 |
MLL | | | | 0 | 0 |
MLL2 | | | | 0 | 0 |
MLL3 | | | | 0 | 0 |
MLLT1 | | | | 0 | 0 |
MLLT3 | | | | 0 | 0 |
mllt4 | | | | 0 | 0 |
MLLT6 | | | | 0 | 0 |
MLST8 | | | | 0 | 0 |
MMP11 | | | | 0 | 0 |
MMP12 | | | | 0 | 0 |
MMP14 | | | | 0 | 0 |
MMP16 | | | | 0 | 0 |
MMP2 | 脑胶质瘤,炎性乳腺癌 | 贝伐单抗, | | 1 | 2 |
MMP3 | | | | 0 | 0 |
MMP9 | 炎性乳腺癌 | 贝伐单抗, | | 1 | 1 |
MMS19 | | | | 0 | 0 |
MN1 | | | | 0 | 0 |
MNAT1 | | | | 0 | 0 |
MNDA | | | | 0 | 0 |
MNX1 | | | | 0 | 0 |
MOCS2 | | | | 0 | 0 |
MOV10L1 | | | | 0 | 0 |
MPL | 原发性血小板增多症,骨髓纤维化 | | | 2 | 2 |
MPO | | | | 0 | 0 |
MRE11 | | | | 0 | 0 |
MRE11A | 子宫内膜癌,前列腺癌 | 他拉唑帕尼,奥拉帕利, | | 2 | 2 |
MRPL19 | | | | 0 | 0 |
MS4A1 | | | | 0 | 0 |
MS4A3 | | | | 0 | 0 |
MSH2 | 林奇综合征,尿路上皮癌 | MEDI0680,MEDI4736, | | 7 | 7 |
MSH3 | | | | 0 | 0 |
MSH4 | | | | 0 | 0 |
MSH5 | | | | 0 | 0 |
MSH6 | 林奇综合征,尿路上皮癌 | MEDI0680,MEDI4736, | | 7 | 7 |
MSI1 | | | | 0 | 0 |
MSI2 | | | | 0 | 0 |
MSN | | | | 0 | 0 |
MSR1 | | | | 0 | 0 |
MST1 | | | | 0 | 0 |
MST1R | | | | 0 | 0 |
MTAP | 乳腺癌 | | 氟尿嘧啶, | 1 | 1 |
MTDH | | | | 0 | 0 |
MTF1 | | | | 0 | 0 |
MTHFD1 | | | | 0 | 0 |
MTHFR | 胰腺癌,直肠癌,胃癌 | | 氟尿嘧啶, | 1 | 3 |
MTMR3 | | | | 0 | 0 |
MTOR | 膀胱癌,乳腺癌,透明细胞肾细胞癌,子宫内膜腺癌,黑色素瘤,肾细胞癌,实体瘤,T细胞急性淋巴细胞白血病,甲状腺癌,尿路上皮癌 | Capivasertib,AZD8055,依维莫司,LY294002,MTOR Inhibitors,帕唑帕尼,培唑帕尼,RapaLink-1,西罗莫司, | 雷帕霉素, | 17 | 21 |
MTR | | | | 0 | 0 |
MTRR | | | | 0 | 0 |
MTUS1 | | | | 0 | 0 |
MUC1 | | | | 0 | 0 |
MUC16 | | | | 0 | 0 |
MUC5B | | | | 0 | 0 |
MUC6 | | | | 0 | 0 |
MUS81 | | | | 0 | 0 |
MUTYH | | | | 0 | 0 |
MX1 | | | | 0 | 0 |
MYADM | | | | 0 | 0 |
MYB | 急性嗜碱性白血病,小儿低级别胶质瘤(PLGG) | | | 2 | 2 |
MYBL1 | | | | 0 | 0 |
MYBL2 | | | | 0 | 0 |
MYC | 食管癌,小细胞肺癌,髓母细胞瘤,多发性骨髓瘤 | 伊布替尼,JQ1,奥拉帕利,Prexasertib, | 顺铂, | 2 | 4 |
MYCL | 多发性骨髓瘤 | GSK1210151A,JQ1, | | 1 | 1 |
MYCN | 髓母细胞瘤,神经母细胞瘤 | CBL0137,GSK126,JQ1,JQEZ5,比拉瑞塞,帕比司他,索尼德吉, | 三氧化二砷, | 1 | 8 |
MYCNOS | | | | 0 | 0 |
MYD88 | 乳腺癌,慢性淋巴细胞白血病,华登斯特巨球蛋白血症 | 伊布替尼,IMG-2005-5,IRAK-1/4 Inhibitor, | 紫杉醇, | 2 | 4 |
MYH10 | | | | 0 | 0 |
MYH11 | | | | 0 | 0 |
MYH14 | | | | 0 | 0 |
MYH9 | | | | 0 | 0 |
MYO10 | | | | 0 | 0 |
MYO18A | | | | 0 | 0 |
MYO1B | | | | 0 | 0 |
MYO3A | | | | 0 | 0 |
MYOD1 | | | | 0 | 0 |
MYOF | | | | 0 | 0 |
MYSM1 | | | | 0 | 0 |